Managing tricuspid valve regurgitation after heart surgery
Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University
Guangdong Provincial People's Hospital · NCT06554119
This study looks at how different surgeries for tricuspid valve regurgitation after heart surgery have worked over the past 25 years to help improve patient outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 375 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Guangdong Provincial People's Hospital (other) |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06554119 on ClinicalTrials.gov |
What this trial studies
This study presents the experience of Guangdong Provincial People's Hospital in managing postoperative tricuspid valve regurgitation over the past 25 years. It aims to analyze the outcomes of various surgical treatments for this condition. By reviewing patient data from 1999 to 2023, the study seeks to identify effective strategies and techniques in addressing complications related to tricuspid valve regurgitation. The observational nature of the study allows for a comprehensive understanding of long-term outcomes following surgical interventions.
Who should consider this trial
Good fit: Ideal candidates are patients who have undergone surgical treatment for tricuspid valve disease following cardiac surgery between 1999 and 2023.
Not a fit: Patients under 16 years old, those with severe tricuspid regurgitation due to primary pulmonary hypertension, and individuals with significant missing case data may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve surgical approaches and outcomes for patients with tricuspid valve regurgitation.
How similar studies have performed: While this study builds on existing knowledge, it focuses on a specific long-term outcome analysis that may not have been extensively covered in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery Exclusion Criteria: age \<16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.
Where this trial is running
Guangzhou, Guangdong
- Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University — Guangzhou, Guangdong, China (RECRUITING)
Study contacts
- Study coordinator: Huanlei Huang
- Email: hhuanlei@hotmail.com
- Phone: 02083827812-10410
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Tricuspid Valve Regurgitation, Complications, Longterm Outcome, tricuspid valve regurgitation, technique advances, complications